GlycoMimetics Total Assets 2012-2020 | GLYC

GlycoMimetics total assets from 2012 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
GlycoMimetics Annual Total Assets
(Millions of US $)
2019 $168
2018 $215
2017 $129
2016 $42
2015 $48
2014 $57
2013 $5
2012 $18
2011 $29
GlycoMimetics Quarterly Total Assets
(Millions of US $)
2020-06-30 $158
2020-03-31 $162
2019-12-31 $168
2019-09-30 $180
2019-06-30 $192
2019-03-31 $204
2018-12-31 $215
2018-09-30 $225
2018-06-30 $236
2018-03-31 $247
2017-12-31 $129
2017-09-30 $116
2017-06-30 $122
2017-03-31 $37
2016-12-31 $42
2016-09-30 $48
2016-06-30 $56
2016-03-31 $41
2015-12-31 $48
2015-09-30 $56
2015-06-30 $62
2015-03-31 $48
2014-12-31 $57
2014-09-30 $62
2014-06-30 $68
2014-03-31 $58
2013-12-31 $5
2013-09-30 $10
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2011-12-31 $29
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.187B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.491B 42.94
Takeda Pharmaceutical (TAK) Japan $57.222B 9.97
Astellas Pharma (ALPMY) Japan $29.044B 0.00
Eisai (ESALY) Japan $25.804B 21.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Merck (MKGAF) Germany $17.189B 0.00
Catalent (CTLT) United States $13.657B 52.80
Grifols, S.A (GRFS) Spain $12.541B 15.33
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.735B 41.56
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.852B 49.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.531B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.992B 11.57
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $5.009B 11.58
Arrowhead Pharmaceuticals (ARWR) United States $4.115B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $3.994B 0.00
Hypermarcas (HYPMY) Brazil $3.957B 14.56
Nektar Therapeutics (NKTR) United States $3.889B 0.00
ChemoCentryx (CCXI) United States $3.417B 0.00
PTC Therapeutics (PTCT) United States $3.238B 0.00
Sage Therapeutics (SAGE) United States $2.632B 0.00
Pacira BioSciences (PCRX) United States $2.494B 65.56
Taro Pharmaceutical Industries (TARO) Israel $2.404B 11.64
Cronos Group (CRON) Canada $1.973B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.849B 0.00
Xencor (XNCR) United States $1.840B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.34
Ironwood Pharmaceuticals (IRWD) United States $1.626B 11.33
Corcept Therapeutics (CORT) United States $1.611B 14.83
Indivior (INVVY) United States $1.548B 19.18
Revolution Medicines (RVMD) United States $1.547B 0.00
Akebia Therapeutics (AKBA) United States $1.430B 0.00
Heron Therapeutics (HRTX) United States $1.391B 0.00
Zogenix (ZGNX) United States $1.345B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.320B 12.60
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.133B 0.00
Karyopharm Therapeutics (KPTI) United States $1.119B 0.00
Translate Bio (TBIO) United States $1.094B 0.00
Esperion Therapeutics (ESPR) United States $1.049B 0.00
VAXART, INC (VXRT) United States $1.004B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.943B 589.50
Tilray (TLRY) Canada $0.931B 0.00
Altimmune (ALT) United States $0.876B 0.00
Endo (ENDP) Ireland $0.779B 1.15
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.708B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.700B 0.00
Trillium Therapeutics (TRIL) Canada $0.699B 0.00
Collegium Pharmaceutical (COLL) United States $0.633B 0.00
Flexion Therapeutics (FLXN) United States $0.608B 0.00
Siga Technologies (SIGA) United States $0.600B 64.00
Aerie Pharmaceuticals (AERI) United States $0.586B 0.00
Radius Health (RDUS) United States $0.557B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.540B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Molecular Templates (MTEM) United States $0.527B 0.00
Ardelyx (ARDX) United States $0.515B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
DURECT (DRRX) United States $0.467B 0.00
TherapeuticsMD (TXMD) United States $0.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.448B 0.00
Ocular Therapeutix (OCUL) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.436B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 10.13
Heat Biologics (HTBX) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.318B 0.00
Harpoon Therapeutics (HARP) United States $0.316B 0.00
IMV INC (IMV) Canada $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.313B 0.00
Redhill Biopharma (RDHL) Israel $0.309B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
MEI Pharma (MEIP) United States $0.295B 0.00
PROFOUND MEDICL (PROF) Canada $0.294B 0.00
Concert Pharmaceuticals (CNCE) United States $0.293B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Lannett Co Inc (LCI) United States $0.251B 5.51
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Aquestive Therapeutics (AQST) United States $0.211B 0.00
Nature's Sunshine Products (NATR) United States $0.210B 20.65
KalVista Pharmaceuticals (KALV) United States $0.207B 0.00
Nivalis Therapeutics (ALPN) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.74
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.137B 0.00
Xeris Pharmaceuticals (XERS) United States $0.126B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
Addex Therapeutics (ADXN) Switzerland $0.115B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
MediWound (MDWD) Israel $0.106B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
Biomerica (BMRA) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Lipocine (LPCN) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.087B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
PolarityTE (PTE) United States $0.059B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
GTx (ONCT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Jaguar Animal Health (JAGX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 8.26
Entasis Therapeutics Holdings (ETTX) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 34.77
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00